Epidemiology and outcomes of ventilator-associated pneumonia in northern Brazil: An analytical descriptive prospective cohort study

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Resende, Marília M ^a,b   Monteiro, Sílvio G ^b,c   Callegari, Bianca ^d   Figueiredo, Patrícia M S ^b   Monteiro, Cinara R A V ^b   Monteiro Neto, Valério ^b,c  

^a Faculdade SEAMA   (Brazil)

^b CEUMA UNIVERSITY   (Brazil)

^c FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^d FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

Bacterial multiresistance; Epidemiology; Invasive mechanical ventilation; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM DERIVATIVE; CEFEPIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LINEZOLID; MEROPENEM; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BRAZIL; CLINICAL ARTICLE; COHORT ANALYSIS; COMORBIDITY; DESCRIPTIVE RESEARCH; ENTEROBACTERIACEAE; FEMALE; HUMAN; INTENSIVE CARE; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PUBLIC HOSPITAL; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BRAZIL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84874497267     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-119     Document Type: Article

References (33)

1. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infection. Am J Infect Control 1988, 16:128-140.
2. American Thoracic S Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416. American Thoracic S.
3. Morehead RS, Pinto SJ. Ventilator-associated pneumonia. Arch Intern Med 2000, 160:1926-1936.
4. Kollef MH, Morrow LE, Niederman MS, Leeper KV, Anzueto A, Benz-Scott L, Rodino FJ. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006, 129:1210-1218.
5. Niederman MS. Cost effectiveness in treating ventilator-associated pneumonia. Crit Care 2001, 5:243-244.
6. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903.
7. Kollef MH. What is ventilator-associated pneumonia and why is it important?. Respir Care 2005, 50:714-721. discussion 721-714.
8. Camargo LF, De Marco FV, Barbas CS, Hoelz C, Bueno MA, Rodrigues M, Amado VM, Caserta R, Martino MD, Pasternak J. Ventilator associated pneumonia: comparison between quantitative and qualitative cultures of tracheal aspirates. Crit Care 2004, 8:R422-R430.
9. Chien JY, Hsueh PR, Yu CJ, Yang PC. The evolution of drug-resistant microorganisms in patients with prolonged mechanical ventilation. Am J Infect Control 2009, 37:231-236.
10. Depuydt PO, Vandijck DM, Bekaert MA, Decruyenaere JM, Blot SI, Vogelaers DP, Benoit DD. Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia. Crit Care 2008, 12:R142.
11. Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998, 157:531-539.
12. Giantsou E, Liratzopoulos N, Efraimidou E, Panopoulou M, Alepopoulou E, Kartali-Ktenidou S, Minopoulos GI, Zakynthinos S, Manolas KI. Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria. Intensive Care Med 2005, 31:1488-1494.
13. Kollef KE, Schramm GE, Wills AR, Reichley RM, Micek ST, Kollef MH. Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest 2008, 134:281-287.
14. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999, 160:608-613.
15. James L, Hoppe-Bauer JE. Processing and interpretation of lower respiratory tract speciments. Clinical microbiology procedures handbook 1997, Washington, DC: ASM Press, Isenberg HD.
16. Ayres M, Ayres MJ, Ayres DL, Santos AS. BioEstat 5.0 2007, Belém, Pará, Brasil: Sociedade Civil Mamirauá. MCT-CNPq, 50.
17. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, Kollef MH, Group VAPOSA Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002, 122:2115-2121. Group VAPOSA.
18. da Silva JM, Rezende E, Guimaraes T, dos Campos EV, Magno LA, Consorti L, Pereira RA, Nascimento Mde L, de Mendonca JS. Epidemiological and microbiological analysis of ventilator-associated pneumonia patients in a public teaching hospital. Braz J Infect Dis 2007, 11:482-488.
19. Guimaraes MM, Rocco JR. Prevalence of ventilator-associated pneumonia in a university hospital and prognosis for the patients affected. J Bras Pneumol 2006, 32:339-346.
20. Rocha Lde A, Vilela CA, Cezario RC, Almeida AB, Gontijo Filho P. Ventilator-associated pneumonia in an adult clinical-surgical intensive care unit of a Brazilian university hospital: incidence, risk factors, etiology, and antibiotic resistance. Braz J Infect Dis 2008, 12:80-85.
21. Rodrigues PM, Carmo Neto E, Santos LR, Knibel MF. Ventilator-associated pneumonia: epidemiology and impact on the clinical evolution of ICU patients. J Bras Pneumol 2009, 35:1084-1091.
22. Erdem I, Ozgultekin A, Inan AS, Dincer E, Turan G, Ceran N, Ozturk Engin D, Senbayrak Akcay S, Akgun N, Goktas P. Incidence, etiology, and antibiotic resistance patterns of gram-negative microorganisms isolated from patients with ventilator-associated pneumonia in a medical-surgical intensive care unit of a teaching hospital in Istanbul, turkey (2004-2006). Jpn J Infect Dis 2008, 61:339-342.
23. Cuellar LE, Fernandez-Maldonado E, Rosenthal VD, Castaneda-Sabogal A, Rosales R, Mayorga-Espichan MJ, Camacho-Cosavalente LA, Castillo-Bravo LI. Device-associated infection rates and mortality in intensive care units of Peruvian hospitals: findings of the international nosocomial infection control consortium. Rev Panam Salud Publica 2008, 24:16-24.
24. Luna CM, Aruj P, Niederman MS, Garzon J, Violi D, Prignoni A, Rios F, Baquero S, Gando S, Grupo Argentino de Estudio de la Neumonia Asociada al Respirador g Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 2006, 27:158-164. Grupo Argentino de Estudio de la Neumonia Asociada al Respirador g.
25. el-Ebiary M, Torres A, Fabregas N, de la Bellacasa JP, Gonzalez J, Ramirez J, del Bano D, Hernandez C, de Anta MT J. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem Histologic study. Am J Respir Crit Care Med 1997, 156(2 Pt 1):583-590.
26. Rello J, Esandi ME, Diaz E, Mariscal D, Gallego M, Valles J. The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients. Chest 1998, 114:146-149.
27. Cook D, Mandell L. Endotracheal aspiration in the diagnosis of ventilator-associated pneumonia. Chest 2000, 117(4 Suppl 2):195S-197S.
28. Combes A, Luyt CE, Fagon JY, Wolff M, Trouillet JL, Chastre J. Impact of piperacillin resistance on the outcome of pseudomonas ventilator-associated pneumonia. Intensive Care Med 2006, 32:1970-1978.
29. Combes A, Luyt CE, Fagon JY, Wollf M, Trouillet JL, Gibert C, Chastre J, Group PT Impact of methicillin resistance on outcome of staphylococcus aureus ventilator-associated pneumonia. Am J Respir Crit Care Med 2004, 170:786-792. Group PT.
30. Horasan ES, Ersoz G, Horoz M, Goksu M, Karacorlu S, Kaya A. Risk factors for infections caused by multidrug-resistant bacteria in patients with solid tumours. Scand J Infect Dis 2011, 43:107-111.
31. Hyllienmark P, Martling CR, Struwe J, Petersson J. Pathogens in the lower respiratory tract of intensive care unit patients: impact of duration of hospital care and mechanical ventilation. Scand J Infect Dis 2012, 44:444-452.
32. Townell NJ, Munckhof WJ, Nimmo G, Bannan A, Holley A, Daniel A, Bennett C, Coulter C, Looke DF. Community-associated methicillin-resistant staphylococcus aureus endocarditis 'down under': case series and literature review. Scand J Infect Dis 2012, 44:536-540.
33. Torres A, Carlet J. Ventilator-associated pneumonia. European task force on ventilator-associated pneumonia. Eur Respir J 2001, 17:1034-1045.